Novel Biomarkers in Chronic Airway Diseases

The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00849836

Enrollment

Registered

2009-02-24

Start date

2009-02-28

Completion date

2010-01-31

Last updated

2009-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, COPD

Brief summary

The purpose of this study is: * To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases. * To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* \> 18 years olds * Both sexes * Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline * Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline * For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Countries

South Korea

Contacts

Primary ContactSo Ri Kim, MD, PhD

sori@chonbuk.ac.kr82-63-250-2475

Backup ContactYong Chul Lee, MD, PhD

leeyc@chonbuk.ac.kr82-63-250-1664

Outcome results